SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INBX, BATL, KAMN

NEW YORK, March 5, 2024

Inhibrx, Inc. (NASDAQ: INBX)'s sale to Sanofi. Under the terms of the proposed transaction, for each Inhibrx share, Inhibrx shareholders will receive $30.00 in cash, a contingent value right of $5.00, conditioned upon the achievement of a regulatory milestone, and 0.25 shares of a new publicly traded company that will retain Inhibrx's non-INBRX-101 assets. If you are a Inhibrx shareholder, click here to learn more about your rights and options.

Battalion Oil Corporation (NYSE: BATL)'s sale to Fury Resources, Inc. for $9.80 per share in cash. If you are a Battalion shareholder, click here to learn more about your rights and options.

Kaman Corp. (NYSE: KAMN)'s sale to Arcline Investment Management, L.P. for $46.00 per share in cash. If you are a Kaman shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.